-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the reform of centralized procurement of medicines and high-value medical consumables has been advancing
.
Up to now, six batches of centralized drug procurement by the state have been carried out, and a total of 234 kinds of drugs have been purchased, with an average price reduction of 53%
.
On the whole, the procurement of national organizations and alliances has formed a normalized pattern
.
It is worth noting that under the background of normalization, centralized procurement has also begun to accelerate and expand
.
Recently, at the regular policy briefing of the State Council, the relevant person in charge of the National Medical Insurance Bureau revealed that by the end of 2022, through the procurement of national organizations and provincial alliances, each province will cover more than 350 varieties of drugs and high-value medical consumables on average.
to 5 or more
.
It is understood that in the national "14th Five-Year Plan" National Medical Security Plan, it has been clearly stated that by 2025, more than 500 varieties of national and provincial drugs will be purchased in a centralized manner in each province
.
The National Medical Insurance Bureau now requires that there will be an average of more than 350 varieties of centralized procurement per province in 2022, and it will take two years to reach 70% of the progress of the five-year plan, and the speed of centralized drug procurement will be significantly accelerated
.
In this regard, the industry believes that this also means that by the end of this year, each province in the country will add an average of 116 varieties of centralized drugs
.
For pharmacies across the country, another large number of drugs ushered in a "price reduction"
.
It is understood that in fact, in recent years, many places are accelerating the promotion of "pharmacy sales of centralized drug collection", and "pharmacy into centralized purchase" has become a national trend
.
For example, in Zibo City, Shandong Province, in October last year, after the launch of "Nationally-sourced Drugs into Pharmacies", the average passenger flow of pharmacies in the city increased by more than 20%, and the average sales volume exceeded 40%
.
In December, the person in charge of the Henan Medical Insurance Bureau also made it clear that this spring, the province will carry out a pilot program of "the first batch of pharmacies to sell and collect medicines"
.
In fact, pharmacies follow up on centralized purchases to reduce prices, which is a strategic choice.
.
Industry insiders said that for retail pharmacies, the era of high gross profit has passed.
Under the influence of national centralized procurement, pharmacy passenger flow has declined, profit margins have been compressed, and follow-up centralized procurement, retail pharmacies can reduce the workload of decentralized procurement in the procurement process; Higher quality service and maintenance provided by pharmaceutical companies; able to obtain better prices than scattered purchases
.
In addition, pharmacies can also increase the variety of prescription drugs through bulk purchases, attracting some customers who used to buy drugs in hospitals to buy prescription drugs in retail pharmacies, increasing customer traffic, and pharmacies can also interact with drug companies and hospitals
.
However, it should be noted that as more and more pharmacies accelerate the sales of centralized drug collection, the industry concentration will continue to increase
.
But in general, if pharmacies continue to add new centralized purchases of lower-priced drugs in the later period, it will actually be a great news for the majority of patients.
In the future, they can buy affordable selected drugs in pharmacies without going to the hospital
.
For pharmacies, the advantages outweigh the disadvantages.
In addition to obtaining lower purchase prices, it is also conducive to the outflow of prescriptions and improving the accessibility of patients
.
.
Up to now, six batches of centralized drug procurement by the state have been carried out, and a total of 234 kinds of drugs have been purchased, with an average price reduction of 53%
.
On the whole, the procurement of national organizations and alliances has formed a normalized pattern
.
It is worth noting that under the background of normalization, centralized procurement has also begun to accelerate and expand
.
Recently, at the regular policy briefing of the State Council, the relevant person in charge of the National Medical Insurance Bureau revealed that by the end of 2022, through the procurement of national organizations and provincial alliances, each province will cover more than 350 varieties of drugs and high-value medical consumables on average.
to 5 or more
.
It is understood that in the national "14th Five-Year Plan" National Medical Security Plan, it has been clearly stated that by 2025, more than 500 varieties of national and provincial drugs will be purchased in a centralized manner in each province
.
The National Medical Insurance Bureau now requires that there will be an average of more than 350 varieties of centralized procurement per province in 2022, and it will take two years to reach 70% of the progress of the five-year plan, and the speed of centralized drug procurement will be significantly accelerated
.
In this regard, the industry believes that this also means that by the end of this year, each province in the country will add an average of 116 varieties of centralized drugs
.
For pharmacies across the country, another large number of drugs ushered in a "price reduction"
.
It is understood that in fact, in recent years, many places are accelerating the promotion of "pharmacy sales of centralized drug collection", and "pharmacy into centralized purchase" has become a national trend
.
For example, in Zibo City, Shandong Province, in October last year, after the launch of "Nationally-sourced Drugs into Pharmacies", the average passenger flow of pharmacies in the city increased by more than 20%, and the average sales volume exceeded 40%
.
In December, the person in charge of the Henan Medical Insurance Bureau also made it clear that this spring, the province will carry out a pilot program of "the first batch of pharmacies to sell and collect medicines"
.
In fact, pharmacies follow up on centralized purchases to reduce prices, which is a strategic choice.
.
Industry insiders said that for retail pharmacies, the era of high gross profit has passed.
Under the influence of national centralized procurement, pharmacy passenger flow has declined, profit margins have been compressed, and follow-up centralized procurement, retail pharmacies can reduce the workload of decentralized procurement in the procurement process; Higher quality service and maintenance provided by pharmaceutical companies; able to obtain better prices than scattered purchases
.
In addition, pharmacies can also increase the variety of prescription drugs through bulk purchases, attracting some customers who used to buy drugs in hospitals to buy prescription drugs in retail pharmacies, increasing customer traffic, and pharmacies can also interact with drug companies and hospitals
.
However, it should be noted that as more and more pharmacies accelerate the sales of centralized drug collection, the industry concentration will continue to increase
.
But in general, if pharmacies continue to add new centralized purchases of lower-priced drugs in the later period, it will actually be a great news for the majority of patients.
In the future, they can buy affordable selected drugs in pharmacies without going to the hospital
.
For pharmacies, the advantages outweigh the disadvantages.
In addition to obtaining lower purchase prices, it is also conducive to the outflow of prescriptions and improving the accessibility of patients
.
